title: Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction.
abstract: Insufficient drug uptake by solid tumors remains the major problem for systemic chemotherapy. Many studies have demonstrated anticancer drug effects to be dose-dependent, although dose-escalation studies have resulted in limited survival benefit with increased systemic toxicities. One solution to this has been the idea of loco-regional drug treatments, which offer dramatically higher drug concentrations in tumor tissues while minimizing systemic toxicity. Although loco-regional delivery has been most prominent in cancers of the liver, soft tissues and serosal peritoneal malignancies, survival benefits are very far from desirable. This review discusses the evolution of loco-regional treatments, the present approaches and offers rapidly reversible hydrophobization of drugs as the new future direction.
authors.affiliation: Madison, WI, USA.
authors.forename: Vladimir G
authors.initials: VG
authors.lastname: Budker
authors.affiliation: 410 W. Harrison St, Seattle, WA 98119, USA.
authors.forename: Sean D
authors.initials: SD
authors.lastname: Monahan
authors.affiliation: 602 Samuel Drive, Madison, WI 53717, USA. Electronic address: vladimir.m.subbotin@gmail.com.
authors.forename: Vladimir M
authors.initials: VM
authors.lastname: Subbotin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D007263:Infusions, Parenteral; D009369:Neoplasms / Q000188:drug therapy*; D011355:Prodrugs / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011355:Prodrugs